Clinical Trials as Topic
"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Descriptor ID |
D002986
|
MeSH Number(s) |
E05.318.760.535 E05.337.250 N05.715.360.775.235 N06.850.520.450.535
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1981 | 0 | 2 | 2 | 1982 | 0 | 2 | 2 | 1983 | 0 | 1 | 1 | 1984 | 0 | 3 | 3 | 1985 | 0 | 7 | 7 | 1986 | 0 | 7 | 7 | 1987 | 0 | 7 | 7 | 1988 | 1 | 6 | 7 | 1989 | 0 | 6 | 6 | 1990 | 1 | 5 | 6 | 1991 | 0 | 1 | 1 | 1993 | 0 | 3 | 3 | 1994 | 1 | 4 | 5 | 1995 | 0 | 3 | 3 | 1996 | 0 | 2 | 2 | 1997 | 1 | 2 | 3 | 1998 | 1 | 5 | 6 | 1999 | 0 | 5 | 5 | 2000 | 1 | 9 | 10 | 2001 | 2 | 6 | 8 | 2002 | 1 | 8 | 9 | 2003 | 4 | 14 | 18 | 2004 | 4 | 12 | 16 | 2005 | 2 | 15 | 17 | 2006 | 3 | 17 | 20 | 2007 | 2 | 8 | 10 | 2008 | 1 | 12 | 13 | 2009 | 2 | 14 | 16 | 2010 | 1 | 11 | 12 | 2011 | 5 | 11 | 16 | 2012 | 8 | 4 | 12 | 2013 | 5 | 4 | 9 | 2014 | 7 | 7 | 14 | 2015 | 6 | 6 | 12 | 2016 | 2 | 9 | 11 | 2017 | 3 | 3 | 6 | 2018 | 3 | 6 | 9 | 2019 | 3 | 5 | 8 | 2020 | 3 | 5 | 8 | 2021 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Krishnan ML, Berry-Kravis E, Capal JK, Carpenter R, Gringras P, Hipp JF, Miller MT, Mingorance A, Philpot BD, Pletcher MT, Rotenberg A, Tjeertes J, Wang PP, Willgoss T, de Wit MC, Jeste SS. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities. Nat Rev Drug Discov. 2021 09; 20(9):653-654.
-
Van Spall HGC, Lala A, Deering TF, Casadei B, Zannad F, Kaul P, Mehran R, Pearson GD, Shah MR, Gulati M, Grines C, Volgman AS, Revkin JH, PiƱa I, Lam CSP, Hochman JS, Simon T, Walsh MN, Bozkurt B. Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
-
Mittal N, Langevin AM, Kyono W, Dickens DS, Grimes A, Salsman JM, Pollock BH, Roth M. Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial. J Adolesc Young Adult Oncol. 2022 02; 11(1):117-121.
-
Broto JM, Jones RL. Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case Studies. Oncology. 2021; 99 Suppl 1:8-16.
-
Tejwani V, Chang HY, Tran AP, Naber JA, Gutzwiller FS, Winders TA, Khurana S, Sumino K, Mosnaim G, Moloney RM. A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA). Ann Allergy Asthma Immunol. 2021 07; 127(1):116-122.e7.
-
Rossi I, Omotosho P, Poirier J, Spagnoli A, Torquati A. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics. Surgery. 2021 03; 169(3):539-542.
-
Denny A, Streitz M, Stock K, Balls-Berry JE, Barnes LL, Byrd GS, Croff R, Gao S, Glover CM, Hendrie HC, Hu WT, Manly JJ, Moulder KL, Stark S, Thomas SB, Whitmer R, Wong R, Morris JC, Lingler JH. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018. Alzheimers Dement. 2020 12; 16(12):1734-1744.
-
Buckley LA, Bebenek I, Cornwell PD, Hodowanec A, Jensen EC, Murphy C, Ghantous HN. Drug Development 101: A Primer. Int J Toxicol. 2020 Sep/Oct; 39(5):379-396.
-
Provencio JJ, Hemphill JC, Claassen J, Edlow BL, Helbok R, Vespa PM, Diringer MN, Polizzotto L, Shutter L, Suarez JI, Stevens RD, Hanley DF, Akbari Y, Bleck TP, Boly M, Foreman B, Giacino JT, Hartings JA, Human T, Kondziella D, Ling GSF, Mayer SA, McNett M, Menon DK, Meyfroidt G, Monti MM, Park S, Pouratian N, Puybasset L, Rohaut B, Rosenthal ES, Schiff ND, Sharshar T, Wagner A, Whyte J, Olson DM. The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting. Neurocrit Care. 2020 08; 33(1):1-12.
-
Farag S, Smith MJ, Fotiadis N, Constantinidou A, Jones RL. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates Curr Treat Options Oncol. 2020 05 27; 21(7):55.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|